Invesco NASDAQ Biotech UCITS ETF Acc
WKNA12CCJ
AssetklasseAktien
43,065€+0,04€
01.10.2025 08:17+0,08%
43,065€+0,04€
01.10.2025 08:17+0,08%
Verkaufen
43,08VerkaufenStück: 813Kaufen
43,245KaufenStück: 810Eröffnung
42,965
Hoch
43,085
Tief
42,965
Umsatz
1.851,13
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index), less fees, expenses and transaction costs. The Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market. The Fund does this through the use of unfunded swaps. The Index is a modified market capitalisation weighted index. The securities eligible for inclusion include common stocks, ordinary shares, ADRs and shares of beneficial interest or limited partnership interests.
Emittent
Invesco Investment Management Ltd
Benchmark
NASDAQ Biotechnology TR
Fondsgröße in Mio.
333,727
Gesamtkostenquote (TER)
0,4 %
Tracking Difference
3,2962
Replikation
Swap-basiert
Fondswährung
USD
Domizil
IE
Fondsauflage
-
Ausschüttung
Thesaurierend
Ausschüttungsintervall
-
NAV
50,2661
NAV Datum
29.9.2025